VectorBuilder / 云舟生物

About VectorBuilder / 云舟生物

VectorBuilder is a global leader in the field of gene delivery technologies. It serves a wide range of clients, including labs and biotech/pharma companies across the globe. The company provides a comprehensive range of gene delivery solutions that cater to all research and clinical needs, from the laboratory bench to bedside patient care.

VectorBuilder operates in the biotechnology market, specifically in the gene delivery sector. The company's business model revolves around providing custom gene delivery solutions to its clients. It offers a rich selection of epitope-tags and promoters, allowing clients to design custom vectors quickly and efficiently. The company's design portal is lauded for its convenience and usefulness, with a straightforward, intuitive interface that allows users to design their constructs easily.

The company generates revenue by charging for its gene delivery solutions. It offers competitive pricing, with no extra cost for aliquoting into working aliquots. The company has recently achieved unicorn status, indicating a valuation of over $1 billion, following a recent cash injection.

VectorBuilder is also expanding its global presence, with a second office established in Kobe, Japan. The company has also launched a gene therapy pilot program for the rare disease Menkes in Japan, demonstrating its commitment to addressing complex health challenges.

In summary, VectorBuilder is a high-value biotech company providing comprehensive gene delivery solutions to a global client base. It has a strong market position, robust financial health, and a promising growth trajectory.